In early July 2026 (reported July 8), Mumbai-based women's-health startup Avni Wellness secured Rs 4 crore — roughly $470,000 — in seed funding led by Proteus Partners, with participation from angel investors including Puru Gupta, Sreejith Moolayil, A. Velumani, and Somya Nigam. The company said it will use the capital to strengthen digital commerce, expand its "cycle nutrition" product range, grow a network of women-led micro-entrepreneurs, and widen its presence across online marketplaces.

Why It Matters

India's women's-health market is enormous and under-penetrated, and toxin-free, reusable menstrual and nutritional products address problems (iron-deficiency anemia, period poverty, PCOS) that affect hundreds of millions. For investors watching femtech's global map, seed rounds like Avni's show that the category's growth story is increasingly a Global South story — where the winning models often pair affordable, science-backed products with distribution innovation (micro-entrepreneur networks) rather than premium DTC hardware. It's a reminder that "femtech" spans everything from $300 smart rings to a better reusable pad, and that the latter can have outsized real-world impact per dollar raised.

Founded in 2021 by Sujata Pawar and Apurv Agarwal, Avni positions itself around science-backed, toxin-free products spanning adolescence, reproductive years, and menopause. Its portfolio includes a patented antimicrobial reusable sanitary pad, a liposomal iron supplement aimed at the widespread iron deficiency among Indian women, and products addressing PCOS, calcium supplementation, urinary and vaginal health, and seed-based hormonal nutrition. The stated mission blends healthcare access with livelihood generation and sustainability — a distinctly emerging-markets flavor of femtech.

The round is small by Western venture standards, but it's a useful signal about where femtech capital is flowing in mid-2026: beyond the US/EU device darlings and into large, underserved markets where menstrual, hormonal, and nutritional health remain structurally neglected. It lands in the same news week as continued femtech momentum elsewhere — Estonia's Muun Health (€700K for wearable hormone monitoring) and Oova's Oura integration — painting a picture of a sector funding both frontier hardware and unglamorous but high-impact fundamentals like iron supplementation and reusable menstrual care.

Sources

Update — 2026-07-11

Initial entry — story first created.